• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Muc5AC在胃癌中的预后价值:一项荟萃分析。

Prognostic value of Muc5AC in gastric cancer: A meta-analysis.

作者信息

Zhang Chuan-Tao, He Ke-Cheng, Pan Fei, Li Yuan, Wu Jiang

机构信息

Chuan-Tao Zhang, Teaching Hospital of Chengdu University of Traditional Chinese Medicine and Sichuan Province Traditional Chinese Medicine Hospital, Chengdu 610041, Sichuan Province, China.

出版信息

World J Gastroenterol. 2015 Sep 28;21(36):10453-60. doi: 10.3748/wjg.v21.i36.10453.

DOI:10.3748/wjg.v21.i36.10453
PMID:26420972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4579892/
Abstract

AIM

To assess the correlation between decreased Muc5AC expression and patients' survival and clinicopathological characteristics by conducting a meta-analysis.

METHODS

Literature searches were performed in PubMed and EMBASE, and 11 studies met our criteria. Summary hazard ratios or odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to estimate the effect. For the pooled analysis of the correlation between decreased Muc5AC expression and clinicopathological characteristics (tumour invasion depth, lymph node metastasis, tumour-node-metastasis stage, tumour size, venous invasion and lymphatic invasion), ORs and their variance were combined to estimate the effect.

RESULTS

Eleven retrospective cohort studies comprising 2135 patients were included to assess the association between Muc5AC expression and overall survival and/or clinicopathological characteristics. Decreased Muc5AC expression was significantly correlated with poor overall survival of gastric cancer patients (pooled HR = 1.35, 95%CI: 1.08-1.7). Moreover, decreased Muc5AC expression was also significantly associated with tumour invasion depth (pooled OR = 2.12, 95%CI: 1.56-2.87) and lymph node metastasis (pooled OR = 1.56, 95%CI: 1.00-2.44) in gastric cancer.

CONCLUSION

Decreased Muc5AC expression might be a poor prognostic predictor for gastric cancer.

摘要

目的

通过进行一项荟萃分析,评估黏蛋白5AC(Muc5AC)表达降低与患者生存率及临床病理特征之间的相关性。

方法

在PubMed和EMBASE中进行文献检索,11项研究符合我们的标准。计算汇总风险比或比值比(OR)及其95%置信区间(CI)以估计效应。对于Muc5AC表达降低与临床病理特征(肿瘤浸润深度、淋巴结转移、肿瘤-淋巴结-转移分期、肿瘤大小、静脉侵犯和淋巴侵犯)之间相关性的汇总分析,合并OR及其方差以估计效应。

结果

纳入11项回顾性队列研究,共2135例患者,以评估Muc5AC表达与总生存期和/或临床病理特征之间的关联。Muc5AC表达降低与胃癌患者较差的总生存期显著相关(汇总HR = 1.35,95%CI:1.08 - 1.7)。此外,Muc5AC表达降低在胃癌中也与肿瘤浸润深度(汇总OR = 2.12,95%CI:1.56 - 2.87)和淋巴结转移(汇总OR = 1.56,95%CI:1.00 - 2.44)显著相关。

结论

Muc5AC表达降低可能是胃癌预后不良的预测指标。

相似文献

1
Prognostic value of Muc5AC in gastric cancer: A meta-analysis.Muc5AC在胃癌中的预后价值:一项荟萃分析。
World J Gastroenterol. 2015 Sep 28;21(36):10453-60. doi: 10.3748/wjg.v21.i36.10453.
2
Decreased Muc5AC expression is associated with poor prognosis in gastric cancer.黏蛋白 5AC 表达降低与胃癌预后不良相关。
Int J Cancer. 2014 Jan 1;134(1):114-24. doi: 10.1002/ijc.28345. Epub 2013 Jul 16.
3
Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.胰岛素样生长因子结合蛋白7(IGFBP7)表达与胃癌临床病理变量之间的关系
J Clin Pathol. 2015 Oct;68(10):795-801. doi: 10.1136/jclinpath-2015-202987. Epub 2015 Jun 4.
4
Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas.MUC1和MUC5AC表达作为胃癌预后指标的作用。
J Surg Oncol. 2003 Aug;83(4):253-60. doi: 10.1002/jso.10222.
5
Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.成纤维细胞生长因子受体4蛋白表达与胃癌的临床病理特征
World J Gastroenterol. 2015 Feb 14;21(6):1838-44. doi: 10.3748/wjg.v21.i6.1838.
6
Meta-analysis of immunohistochemical expression of hypoxia inducible factor-1α as a prognostic role in gastric cancer.缺氧诱导因子-1α免疫组化表达在胃癌预后中的作用的Meta分析。
World J Gastroenterol. 2014 Jan 28;20(4):1107-13. doi: 10.3748/wjg.v20.i4.1107.
7
Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.丙酮酸脱氢酶的表达是胃癌的一个独立预后标志物。
World J Gastroenterol. 2015 May 7;21(17):5336-44. doi: 10.3748/wjg.v21.i17.5336.
8
Abnormal β-catenin immunohistochemical expression as a prognostic factor in gastric cancer: a meta-analysis.异常β-连环蛋白免疫组化表达作为胃癌预后因素的Meta分析
World J Gastroenterol. 2014 Sep 14;20(34):12313-21. doi: 10.3748/wjg.v20.i34.12313.
9
Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer.脊椎蛋白-2表达升高与胃癌的进展及预后相关。
Oncotarget. 2017 Feb 7;8(6):10416-10424. doi: 10.18632/oncotarget.14423.
10
Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.组蛋白去乙酰化酶10表达降低预示着胃癌患者预后不良。
Int J Clin Exp Pathol. 2014 Aug 15;7(9):5872-9. eCollection 2014.

引用本文的文献

1
The Role of Mucins in Cancer and Cancer Progression: A Comprehensive Review.黏蛋白在癌症及癌症进展中的作用:综述
Curr Issues Mol Biol. 2025 May 29;47(6):406. doi: 10.3390/cimb47060406.
2
A Resected Case of Metachronous Gallbladder Metastasis of Gastric Cancer Mimicking Gallbladder Cancer.一例误诊为胆囊癌的胃癌异时性胆囊转移瘤切除病例
Surg Case Rep. 2025;11(1). doi: 10.70352/scrj.cr.25-0093. Epub 2025 Jun 24.
3
Clinicopathological significance and prognostic values of claudin18.2 expression in solid tumors: a systematic review and meta-analysis.紧密连接蛋白18.2在实体瘤中的表达的临床病理意义及预后价值:一项系统评价与荟萃分析
Front Oncol. 2024 Nov 20;14:1453906. doi: 10.3389/fonc.2024.1453906. eCollection 2024.
4
Detailed survey of an intestinal epithelium model by single-cell transcriptomics.通过单细胞转录组学对肠道上皮模型进行详细研究。
iScience. 2024 Mar 1;27(4):109383. doi: 10.1016/j.isci.2024.109383. eCollection 2024 Apr 19.
5
Single-cell Profiling Uncovers a -Expressing Metaplastic Gastric Cell Type Sustained by -driven Inflammation.单细胞分析揭示了一种由 -driven 炎症维持的表达 - 的胃上皮细胞亚型。
Cancer Res Commun. 2023 Sep 5;3(9):1756-1769. doi: 10.1158/2767-9764.CRC-23-0142. eCollection 2023 Sep.
6
Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma.黏蛋白 5AC 表达常见,但与胰腺腺癌的肿瘤进展无关。
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221106504. doi: 10.1177/03946320221106504.
7
Spatial Proteomic Analysis of Isogenic Metastatic Colorectal Cancer Cells Reveals Key Dysregulated Proteins Associated with Lymph Node, Liver, and Lung Metastasis.同基因转移性结直肠癌细胞的空间蛋白质组学分析揭示了与淋巴结、肝和肺转移相关的关键失调蛋白。
Cells. 2022 Jan 27;11(3):447. doi: 10.3390/cells11030447.
8
MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10 399 Tissue Samples.MUC5AC 在各种肿瘤类型和非肿瘤组织中的表达:10399 个组织样本的组织微阵列研究。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211043328. doi: 10.1177/15330338211043328.
9
Low level of microsatellite instability correlates with short disease-free survival of gastric cancer patients undergoing neoadjuvant chemotherapy.低微卫星不稳定性水平与接受新辅助化疗的胃癌患者无病生存时间短相关。
Virchows Arch. 2021 Feb;478(2):231-240. doi: 10.1007/s00428-020-02878-6. Epub 2020 Jun 25.
10
Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.鉴定胃癌的新型生物标志物:黏蛋白 5AC(MUC5AC)、黏蛋白 1(MUC1)、角蛋白 7(KRT7)、甘油醛 3-磷酸脱氢酶(GAPDH)、CD44。
Med Oncol. 2020 Mar 27;37(5):34. doi: 10.1007/s12032-020-01362-0.

本文引用的文献

1
Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomach.胃腺体黏蛋白特异性 O-聚糖的丢失与胃分化型腺癌的进展相关。
Cancer Sci. 2014 Jan;105(1):126-33. doi: 10.1111/cas.12305. Epub 2013 Nov 22.
2
Mucin expression in gastric cancer: reappraisal of its clinicopathologic and prognostic significance.胃癌中黏蛋白的表达:重新评估其临床病理和预后意义。
Arch Pathol Lab Med. 2013 Aug;137(8):1047-53. doi: 10.5858/arpa.2012-0193-OA.
3
Decreased Muc5AC expression is associated with poor prognosis in gastric cancer.黏蛋白 5AC 表达降低与胃癌预后不良相关。
Int J Cancer. 2014 Jan 1;134(1):114-24. doi: 10.1002/ijc.28345. Epub 2013 Jul 16.
4
Technical note: The risk ratio, an alternative to the odds ratio for estimating the association between multiple risk factors and a dichotomous outcome.技术说明:风险比是一种替代优势比的方法,用于估计多个危险因素与二分类结局之间的关联。
J Dairy Sci. 2012 May;95(5):2576-84. doi: 10.3168/jds.2011-4515.
5
Histotype-based prognostic classification of gastric cancer.基于组织学分型的胃癌预后分类。
World J Gastroenterol. 2012 Mar 7;18(9):896-904. doi: 10.3748/wjg.v18.i9.896.
6
Novel immunotherapeutic strategies of gastric cancer treatment.胃癌治疗的新型免疫治疗策略。
J Biomed Biotechnol. 2011;2011:437348. doi: 10.1155/2011/437348. Epub 2011 Dec 27.
7
The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer.化生标志物的联合表达可预测胃癌的预后。
Ann Surg Oncol. 2012 Apr;19(4):1240-9. doi: 10.1245/s10434-011-2125-1. Epub 2011 Nov 3.
8
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.2008 年全球癌症负担估计值:GLOBOCAN 2008。
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
9
Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma.MUC1、MUC2和MUC5AC在胃癌中的表达及其预后意义
Turk J Gastroenterol. 2010 Dec;21(4):345-52. doi: 10.4318/tjg.2010.0119.
10
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.